DW Insights & Inquiries
Over the past 20 years, 6 systemic therapies have been FDA approved to fill the gap between the familiar skin-directed treatments and the traditional cytotoxic chemotherapeutic agents that were previously the one option for advanced disease.
he global pandemic caused by COVID-19 has heightened the need to use PPE as a safety precaution, highlighting the problems associated with infection-prevention measures, most notably masks and gloves.
Fortunately, there have been very few domesticated animals that have been reported to have been infected with SARS-CoV-2. With this knowledge, pets are not believed to play a major role in transmission of this coronavirus to humans.
According to Lambru et al, RES episodes are characterized by mostly unilateral, or occasionally bilateral, attacks of paroxysmal burning sensations and reddening of the external ear.
Chances are you will see patients with at least one pilar cyst today. You will reassure them of their benignity, stating that the risk of their becoming cancerous is infinitesimal, and perhaps you will excise some lesions.
If you have not yet seen any adverse reactions to ibrutinib, it will not be long before you do. From a dermatologist’s vantage point, there are several presentations, related to ibrutinib’s mechanism and the underlying condition.
The goal of this website is to improve the practice of dermatology, while being stimulating, practical, thought-provoking, and enlightening. Perspectives on current dermatologic literature are offered that are meant to be used in the clinic.
Explore Dermatology World Insights and Inquiries clinical topics by practice focus, condition, and medical journal source.